ASCENTRA-UC expected to enroll up to 204 patients with moderately to severely active ulcerative colitis across North America ...
French biotech company Abivax said new clinical trial data supports the safety and effectiveness of its experimental ...
Abivax Reports Positive ABTECT Maintenance Part 2 Results for Obefazimod, Demonstrating Meaningful Clinical Benefit in Refractory Ulcerative ...
U.S.-listed shares of Abivax climbed more than 25% in after-hours trading after the French biotech released new data aimed at ...
Shares of French biotech company Abivax soared Tuesday after it released fresh data on its lead drug for bowel disease.
Abivax said on Monday its experimental ulcerative colitis drug helped harder-to-treat groups of patients achieve remission, ...
On June 29, 2026, Abivax reported positive topline data from Part 2 of its 44-week Phase 3 ABTECT maintenance trial of obefazimod in moderate to severely active ulcerative colitis. The supplemental ...
Ulcerative colitis is a chronic condition that affects the large intestines, particularly the colon. It is classified as one of the two inflammatory bowel diseases along with Crohn’s disease. The ...
7d
Woman died during surgery after being forced to wait a year for prescribed ulcerative colitis drug
A coroner found a series of failings in Theresa Lydon's care, including delays in medication and missed opportunities to ...
'Imagine having a wound that never heals. Only it’s on the inside and every time you eat or drink, it’s like rubbing salt into that wound.' When asked to explain the sensation of ulcerative colitis, ...
Add Yahoo as a preferred source to see more of our stories on Google. I first started having symptoms of ulcerative colitis when I was 18. I had just enlisted in the Air Force and was on assignment in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results